FDA Guidance Steps Up Push to Speed Generics to Market

Drug Industry Daily
As part of a broad effort to increase competition and lower drug prices, the FDA spelled out what it expects from sponsors of abbreviated new generic drug applications who are seeking early meetings to smooth the approval review process.

To View This Article:


Subscribe To Drug Industry Daily